Neural Implants Global Market Report 2026

Neural implants, also referred to as brain-computer interfaces (BCIs) or neural prosthetics, are medical devices designed to interact with the nervous system, aiming to restore or enhance neural function. These implants are intended for restoring sensory functions, treating neurological disorders, and enhancing cognitive abilities.

The primary types of neural implant products include Frequency and Burst (F and B) spinal cord stimulation (SCS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS). F and B Spinal Cord Stimulation (SCS) devices are small implants that deliver electrical signals to the spinal cord, aiding in the treatment of chronic pain. They find applications in various conditions such as chronic pain, Parkinson's disease (PD), epilepsy, among others, and are utilized by various end-users such as hospitals, specialized neurological centers (SNCs), and outpatient surgery centers.

Tariffs are impacting the neural implants market by increasing costs of imported electronic components, microprocessors, and precision materials used in implantable neurostimulation devices. These effects are most pronounced in north america and europe, where advanced implants rely heavily on global component sourcing. Higher manufacturing costs have influenced pricing for hospitals and specialized neurological centers. On the positive side, tariffs are encouraging local manufacturing, supplier diversification, and innovation in cost-optimized implant design.

The neural implants market research report is one of a series of new reports from The Business Research Company that provides neural implants market statistics, including neural implants industry global market size, regional shares, competitors with a neural implants market share, detailed neural implants market segments, market trends and opportunities, and any further data you may need to thrive in the neural implants industry. This neural implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neural implants market size has grown rapidly in recent years. It will grow from $5.91 billion in 2025 to $6.53 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, growth in chronic pain patient population, rising adoption of deep brain stimulation therapies, expansion of neurology specialty centers, increasing clinical evidence supporting neuromodulation.

The neural implants market size is expected to see strong growth in the next few years. It will grow to $9.2 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to advancements in implantable neurotechnology, growing geriatric population with neurological conditions, rising demand for personalized neurology treatments, expansion of outpatient neurological procedures, increasing investment in neurotechnology research. Major trends in the forecast period include rising adoption of neurostimulation therapies for chronic disorders, growing use of implantable devices for movement disorders, increasing clinical acceptance of brain-computer interface technologies, expansion of neuromodulation applications beyond pain management, rising demand for long-term neurological disorder management solutions.

The increasing prevalence of neurological disorders is expected to drive the growth of the neural implants market in the coming years. Neurological disorders are conditions affecting the nervous system, involving anatomical, biochemical, or electrical abnormalities in the brain, spinal cord, or peripheral nerves. The incidence of these disorders has risen due to factors such as aging populations, genetic predispositions, and changes in diagnostic criteria. Neural implants treat and manage various neurological diseases by interfacing directly with the nervous system to restore or enhance neural functions. These implants offer a personalized approach, potentially improving therapy effectiveness while reducing adverse effects, particularly in conditions such as Parkinson's disease, epilepsy, and spinal cord injuries. For example, in 2024, according to the Department of Health and Human Services, a US-based federal department responsible for protecting public health, more than 6 million Americans were living with Alzheimer's disease in 2023, with projections indicating this number could reach 13 million by 2060 as the population ages. Therefore, the rising prevalence of neurological disorders is fueling the growth of the neural implants market.

Key players in the neural implant market are concentrating on developing innovative products, such as deep brain stimulation (DBS) devices, to treat movement disorders such as Parkinson's disease and essential tremors, thereby gaining a competitive advantage in the market. Deep Brain Stimulation (DBS) devices are implants used to treat neurological disorders by delivering electrical impulses to specific brain areas. For example, in January 2024, Abbott Laboratories introduced Liberta RC, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, designed for individuals with movement disorders. It requires minimal recharges, approximately 10 sessions per year for most users, and is connected to Abbott's NeuroSphere virtual clinic for remote clinician contact, setting confirmation, and updated treatment adjustments. The device includes a wireless charger for convenience, allowing users to remain active while charging. It also offers customizable notifications and settings for a personalized user experience.

In October 2023, Butterfly Network partnered with Forest Neurotech to develop a minimally invasive whole-brain neural interface using ultrasound technology. This collaboration aims to revolutionize brain-computer interfaces and advance personalized treatments for various neurological and cognitive conditions. Forest Neurotech specializes in ultrasound-based brain-computer interfaces (BCIs) and software platforms, contributing to the advancement of neuroscience and patient care.

Major companies operating in the neural implants market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp., NeuroPace Inc., Axonics Modulation Technologies Inc., Saluda Medical, Nuvectra Corporation, Cerbomed GmbH, Inspire Medical Systems Inc., Synchron Inc., Blackrock Neurotech, Neuralink, BrainGate, Bioinduction Ltd, SetPoint Medical, CereGate, Gyrus ACMI, Aleva Neurotherapeutics

North America was the largest region in the neural implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neural implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neural implants market consists of sales of electrodes, implantable devices, connectivity modules, surgical tools, and accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neural Implants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neural implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neural implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neural implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: F And B Spinal Cord Stimulation (SCS); Deep Brain Stimulation (DBS); Vagus Nerve Stimulation (VNS)
• 2) By Application: Chronic Pain; Parkinson's Disease (PD); Epilepsy; Other Applications
• 3) By End-User: Hospitals; Specialized Neurological Centers (SNCs); Outpatient Surgery Centers
• Subsegments:
• 1) By F And B Spinal Cord Stimulation (SCS): Traditional Spinal Cord Stimulation; High-Frequency Spinal Cord Stimulation; Burst Spinal Cord Stimulation
• 2) By Deep Brain Stimulation (DBS): Subthalamic Nucleus (Stn) Dbs; Globus Pallidus Internus (Gpi) Dbs; Ventral Intermediate Nucleus (Vim) Dbs
• 3) By Vagus Nerve Stimulation (VNS): Implantable Vagus Nerve Stimulators; Non-Invasive Vagus Nerve Stimulators
• Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; LivaNova PLC; Nevro Corp.; NeuroPace Inc.; Axonics Modulation Technologies Inc.; Saluda Medical; Nuvectra Corporation; Cerbomed GmbH; Inspire Medical Systems Inc.; Synchron Inc.; Blackrock Neurotech; Neuralink; BrainGate; Bioinduction Ltd; SetPoint Medical; CereGate; Gyrus ACMI; Aleva Neurotherapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.